What's new

Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Feb 20, 2025 - 15:10
 0
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Orphan designation: N-(2-Methoxyethyl)-6-methyl-N-[(3-methyl-2-thienyl)methyl]-2...

Next Article

Revisiting the kinetics enhancement strategies of Si anodes through deconstructi...

Related Posts

Herbal medicinal product: Anisi aetheroleumArray, F: Assessment finalised

Herbal medicinal product: Anisi aetheroleumArray, F: As...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

EMEA-002798-PIP04-23

EMEA-002798-PIP04-23

Feb 13, 2025  0